$0.8973
0.0283[3.26%]
At close: Apr 23
$0.8973
0[0.00%]
After Hours: 8:52AM EDT
Mainz Biomed
(NASDAQ:MYNZ)Latest News for Mainz Biomed Stock (NASDAQ:MYNZ)
Mainz Biomed Stock (NASDAQ: MYNZ)
Categories: All
Friday, April 12, 2024
Wednesday, April 10, 2024
Tuesday, April 02, 2024
Monday, March 18, 2024
Tuesday, March 12, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Wednesday, February 28, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Thursday, February 01, 2024
- Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The SaddleUpwallstreet - Feb 1, 2024, 2:17PM
- 2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The ChargeFaith Ashmore - Sponsored
Thursday, January 11, 2024
Tuesday, January 09, 2024
Friday, December 29, 2023
Wednesday, December 20, 2023
Tuesday, December 12, 2023
Tuesday, December 05, 2023
- Mainz Biomed shares are trading lower. The company reported topline results from U.S. eAArly DETECT Study evaluating novel mRNA biomarkers.Benzinga Newsdesk - Dec 5, 2023, 3:00PM
- Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Dec 5, 2023, 1:06PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Dec 5, 2023, 12:31PM
- While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal CancerUpwallstreet - Dec 5, 2023, 12:06PM
- Mainz Biomed Reports Topline Results From U.S. eAArly DETECT Study Evaluating Novel mRNA BiomarkersBenzinga Newsdesk - Dec 5, 2023, 9:03AM
Wednesday, November 29, 2023
Tuesday, November 21, 2023
Monday, November 20, 2023
Thursday, November 16, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Nov 16, 2023, 4:31PM
- CORRECTION: Mainz Biomed Q3 EPS $(0.39) Beats $(0.47) Estimate, Sales $181.67K Miss $330.00K EstimateBenzinga Newsdesk - Nov 16, 2023, 8:11AM
- Mainz Biomed Q3 EPS $(0.39) Beats $(0.47) Estimate, Sales $181.67K Miss $330.00K EstimateBenzinga Newsdesk - Nov 16, 2023, 8:07AM
Tuesday, November 14, 2023
Monday, November 13, 2023
- Crude Oil Gains Over 1%; US Budget Deficit Narrows For OctoberLisa Levin - Nov 13, 2023, 2:35PM
- Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Nov 13, 2023, 1:08PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Nov 13, 2023, 12:31PM
- Why Mainz Biomed (MYNZ) Stock Is Getting HammeredHenry Khederian - Nov 13, 2023, 12:27PM
- Mainz Biomed shares are trading lower after the company announced pricing of a $5 million registered direct offering.Benzinga Newsdesk - Nov 13, 2023, 12:26PM
- Dow Surges 100 Points; Tenax Therapeutics Shares Spike HigherLisa Levin - Nov 13, 2023, 12:03PM
- US Stocks Fall; Tyson Foods Posts Upbeat EarningsLisa Levin - Nov 13, 2023, 9:47AM
- Mainz Biomed Announces Pricing Of $5M Registered Direct Offering Of 4,166,667 Shares At $1.20/ShareBenzinga Newsdesk - Nov 13, 2023, 9:01AM
- Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening TestFaith Ashmore - Sponsored
Thursday, November 09, 2023
Tuesday, November 07, 2023
- AI Meets Oncology! Mainz Biomed Inks Pact With Liquid Biosciences To Develop Next-Gen Colorectal Cancer Screening TestNabaparna Bhattacharya - Nov 7, 2023, 3:27PM
- BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection TestUpwallstreet - Nov 7, 2023, 10:10AM
- Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer DetectionFaith Ashmore - Sponsored